FDA orders halt in enrollment in clinical trial for diabetes drug Avandia
Date: 2010-07-21T11:16:37.023 Author: AAA Staff Editor note: WASHINGTON – The FDA today ordered drug maker GlaxoSmithKline to stop enrolling new patients in a controversial clinical trial of its widely marketed diabetes drug, Avandia.
One of the 17 sites that has been enlisting patients for the study, comparing the safety of Avandia to another drug, Actos, is in Haverhill; the doctor overseeing patients for that location in the trial, Dr. Seth Bilazarian, has declined to say how many patients he has recruited in the trial thus far. Bilazarian did not Number of Views: 304
View original artilce: http://www.boston.com/news/politics/politicalintelligence/2010/07/fda_orders_halt.html
|
|
|
|
|
|
|
|
|
|
|
Return
|
You must be Registered to Post